Financial Ratios Precision System Science Co., Ltd.
Stocks
7707
JP3833400009
Advanced Medical Equipment & Technology
|
Market Closed -
Japan Exchange
02:30:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 219.00 JPY | -1.35% |
|
+3.79% | +17.74% |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.21 | 0.83 | -6.57 | -7.4 | -1.35 | |||||
Return on Total Capital | 7.17 | 0.92 | -7.09 | -8.2 | -1.55 | |||||
Return On Equity % | 14.59 | 0.69 | -22.57 | -23.95 | -6.4 | |||||
Return on Common Equity | 14.59 | 0.69 | -22.57 | -23.95 | -6.4 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 33.31 | 33.45 | 25.58 | 23.85 | 29.41 | |||||
SG&A Margin | 17.76 | 26.15 | 39.66 | 42.47 | 29.28 | |||||
EBITDA Margin % | 13.64 | 9.24 | -8.92 | -13.77 | 2.47 | |||||
EBITA Margin % | 9.63 | 2.06 | -21.07 | -24.05 | -2.6 | |||||
EBIT Margin % | 9.63 | 2.06 | -21.07 | -24.05 | -2.6 | |||||
Income From Continuing Operations Margin % | 8.55 | 0.61 | -25.09 | -28.17 | -5.39 | |||||
Net Income Margin % | 8.55 | 0.61 | -25.09 | -28.17 | -5.39 | |||||
Net Avail. For Common Margin % | 8.55 | 0.61 | -25.09 | -28.17 | -5.39 | |||||
Normalized Net Income Margin | 5.18 | 1.48 | -13.52 | -15.86 | -1.86 | |||||
Levered Free Cash Flow Margin | -25.99 | -18.96 | 6.8 | 18.08 | 4.05 | |||||
Unlevered Free Cash Flow Margin | -25.88 | -18.64 | 7.28 | 18.57 | 4.32 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.03 | 0.65 | 0.5 | 0.49 | 0.83 | |||||
Fixed Assets Turnover | 5.53 | 2.43 | 1.47 | 1.61 | 3.1 | |||||
Receivables Turnover (Average Receivables) | 5.31 | 4.11 | 4.23 | 5.46 | 7.13 | |||||
Inventory Turnover (Average Inventory) | 3.62 | 2.47 | 1.98 | 1.58 | 2.07 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.41 | 3.15 | 2.93 | 2.35 | 2.94 | |||||
Quick Ratio | 1.79 | 2.23 | 1.76 | 1.42 | 1.55 | |||||
Operating Cash Flow to Current Liabilities | -0.08 | 0.39 | -0 | -0.05 | 0.08 | |||||
Days Sales Outstanding (Average Receivables) | 68.72 | 88.75 | 86.2 | 67.06 | 51.23 | |||||
Days Outstanding Inventory (Average Inventory) | 100.92 | 147.9 | 184.68 | 231.8 | 176.11 | |||||
Average Days Payable Outstanding | 35.23 | 45.86 | 30.12 | 48.02 | 42.64 | |||||
Cash Conversion Cycle (Average Days) | 134.41 | 190.78 | 240.76 | 250.84 | 184.69 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 56.04 | 61.73 | 74.05 | 32.96 | 15 | |||||
Total Debt / Total Capital | 35.91 | 38.17 | 42.54 | 24.79 | 13.05 | |||||
LT Debt/Equity | 19.52 | 41.04 | 48.3 | 6.98 | 0.8 | |||||
Long-Term Debt / Total Capital | 12.51 | 25.38 | 27.75 | 5.25 | 0.69 | |||||
Total Liabilities / Total Assets | 43.14 | 42.94 | 46.51 | 35.24 | 23.86 | |||||
EBIT / Interest Expense | 55.94 | 4.03 | -27.8 | -30.87 | -6.1 | |||||
EBITDA / Interest Expense | 79.25 | 18.08 | -11.78 | -17.68 | 5.8 | |||||
(EBITDA - Capex) / Interest Expense | -24.88 | -33.39 | -15.15 | -18.06 | 3.15 | |||||
Total Debt / EBITDA | 2.91 | 5.85 | -8.21 | -2.49 | 4.86 | |||||
Net Debt / EBITDA | -0.28 | 1.83 | -3.01 | 1 | -4.07 | |||||
Total Debt / (EBITDA - Capex) | -9.26 | -3.17 | -6.38 | -2.44 | 8.95 | |||||
Net Debt / (EBITDA - Capex) | 0.89 | -0.99 | -2.34 | 0.98 | -7.49 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 83.5 | -20.05 | -29 | -24.61 | 17.92 | |||||
Gross Profit, 1 Yr. Growth % | 98.91 | -19.7 | -45.72 | -29.7 | 45.42 | |||||
EBITDA, 1 Yr. Growth % | 3.15K | -45.82 | -168.56 | 16.35 | -121.17 | |||||
EBITA, 1 Yr. Growth % | -1.19K | -82.91 | -826.8 | -13.94 | -87.25 | |||||
EBIT, 1 Yr. Growth % | -1.19K | -82.91 | -826.8 | -13.94 | -87.25 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -797.37 | -94.34 | -3.04K | -15.33 | -77.43 | |||||
Net Income, 1 Yr. Growth % | -797.37 | -94.34 | -3.04K | -15.33 | -77.43 | |||||
Normalized Net Income, 1 Yr. Growth % | -936.96 | -77.14 | -748.86 | -11.56 | -86.14 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -761.58 | -94.4 | -3.04K | -15.33 | -77.32 | |||||
Accounts Receivable, 1 Yr. Growth % | 22.85 | -12.69 | -52.05 | -19.55 | 2.62 | |||||
Inventory, 1 Yr. Growth % | 74.1 | -15.93 | 17.09 | -20.99 | -11.33 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 115 | 67 | -11.93 | -53.17 | -8.61 | |||||
Total Assets, 1 Yr. Growth % | 79.74 | -1.37 | -14.45 | -34.47 | -22.81 | |||||
Tangible Book Value, 1 Yr. Growth % | 49.37 | -5.06 | -19.94 | -17.9 | -8.19 | |||||
Common Equity, 1 Yr. Growth % | 52.27 | -1.02 | -19.81 | -20.67 | -9.25 | |||||
Cash From Operations, 1 Yr. Growth % | 1.23K | -410.36 | -100.69 | 1.67K | -189.62 | |||||
Capital Expenditures, 1 Yr. Growth % | 697.13 | 17.41 | -93.1 | -91.11 | 341.67 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -3.62K | -41.69 | -125.48 | 100.42 | -73.56 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -3.36K | -42.44 | -127.72 | 92.42 | -72.56 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 45.68 | 21.13 | -24.66 | -26.84 | -5.71 | |||||
Gross Profit, 2 Yr. CAGR % | 41.31 | 26.38 | -33.98 | -38.23 | 1.1 | |||||
EBITDA, 2 Yr. CAGR % | 125.66 | 319.71 | -39.05 | -10.69 | -50.37 | |||||
EBITA, 2 Yr. CAGR % | 133.61 | 36.6 | 11.47 | 150.1 | -66.88 | |||||
EBIT, 2 Yr. CAGR % | 133.61 | 36.6 | 11.47 | 150.1 | -66.88 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 147.29 | -37.17 | 29.05 | 399.11 | -56.29 | |||||
Net Income, 2 Yr. CAGR % | 147.29 | -37.17 | 29.05 | 399.11 | -56.29 | |||||
Normalized Net Income, 2 Yr. CAGR % | 136.21 | 38.31 | 21.78 | 139.55 | -64.99 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 134.1 | -39.15 | 28.32 | 399.13 | -56.18 | |||||
Accounts Receivable, 2 Yr. CAGR % | 26.87 | 3.56 | -35.3 | -37.89 | -9.14 | |||||
Inventory, 2 Yr. CAGR % | 24.24 | 20.98 | -0.78 | -3.81 | -16.3 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 76.07 | 89.48 | 21.28 | -35.78 | -34.58 | |||||
Total Assets, 2 Yr. CAGR % | 44.97 | 33.15 | -8.14 | -25.13 | -28.88 | |||||
Tangible Book Value, 2 Yr. CAGR % | 27.09 | 19.08 | -12.82 | -18.93 | -13.18 | |||||
Common Equity, 2 Yr. CAGR % | 28.62 | 22.77 | -10.91 | -20.24 | -15.15 | |||||
Cash From Operations, 2 Yr. CAGR % | -16.65 | 543.28 | -85.36 | -65.07 | 297.91 | |||||
Capital Expenditures, 2 Yr. CAGR % | 332.66 | 205.92 | -71.53 | -92.17 | -37.34 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 130.18 | 352.73 | -61.46 | -28.54 | -27.2 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 131.13 | 333.41 | -60.06 | -26.97 | -27.34 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 36.69 | 19.28 | 1.37 | -24.64 | -14.22 | |||||
Gross Profit, 3 Yr. CAGR % | 33.15 | 17.05 | -4.64 | -32.58 | -17.83 | |||||
EBITDA, 3 Yr. CAGR % | 61.33 | 40.26 | 129.43 | -24.39 | -44.73 | |||||
EBITA, 3 Yr. CAGR % | 32.47 | -2.29 | 138.47 | 2.26 | -7.27 | |||||
EBIT, 3 Yr. CAGR % | 32.47 | -2.29 | 138.47 | 2.26 | -7.27 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.27 | -29.79 | 126.46 | 12.14 | 77.82 | |||||
Net Income, 3 Yr. CAGR % | 20.27 | -29.79 | 126.46 | 12.14 | 77.82 | |||||
Normalized Net Income, 3 Yr. CAGR % | 25.67 | 8.45 | 131.54 | 9.47 | -7.34 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 13.67 | -32.56 | 121.68 | 11.71 | 78.12 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.55 | 12.01 | -19.88 | -30.43 | -26.58 | |||||
Inventory, 3 Yr. CAGR % | 22.25 | 9.07 | 19.67 | -8.04 | -6.39 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 48.54 | 72.99 | 46.78 | -11.69 | -27.76 | |||||
Total Assets, 3 Yr. CAGR % | 31.15 | 27.51 | 14.89 | -17.92 | -24.36 | |||||
Tangible Book Value, 3 Yr. CAGR % | 24.93 | 15.31 | 4.32 | -14.55 | -15.5 | |||||
Common Equity, 3 Yr. CAGR % | 25.95 | 17.87 | 6.52 | -14.29 | -16.73 | |||||
Cash From Operations, 3 Yr. CAGR % | 106.06 | 29.19 | -34.14 | -27.66 | -52.18 | |||||
Capital Expenditures, 3 Yr. CAGR % | 148.93 | 180.11 | -13.56 | -80.69 | -69.96 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 817.88 | 45.64 | 73.49 | -33.23 | -48.7 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 719.36 | 45.42 | 73.32 | -32.54 | -47.3 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 15.84 | 14.08 | 7.71 | -1.91 | -1.53 | |||||
Gross Profit, 5 Yr. CAGR % | 17.24 | 13.06 | 0.57 | -9.36 | -2.38 | |||||
EBITDA, 5 Yr. CAGR % | 23.24 | 15.38 | 9.3 | 17.09 | 24.36 | |||||
EBITA, 5 Yr. CAGR % | 4.1 | -19.04 | 23.63 | 42.3 | 8.27 | |||||
EBIT, 5 Yr. CAGR % | 3.93 | -19.04 | 23.63 | 42.3 | 8.27 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -14.71 | -39.5 | 23.71 | 53.86 | 17.29 | |||||
Net Income, 5 Yr. CAGR % | -12.86 | -39.5 | 23.71 | 53.86 | 17.29 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.57 | -16.28 | 24.1 | 48.9 | 8.76 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -17.96 | -42.75 | 19.32 | 50.18 | 15.91 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.03 | 15.49 | -2.77 | -11.53 | -15.75 | |||||
Inventory, 5 Yr. CAGR % | 13.6 | 4.79 | 12.46 | 3.72 | 3.72 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 26.51 | 40.13 | 36.96 | 16.38 | 6.24 | |||||
Total Assets, 5 Yr. CAGR % | 14.73 | 14.48 | 13.74 | 3.05 | -5.16 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.61 | 10.2 | 8.18 | 0.16 | -3.07 | |||||
Common Equity, 5 Yr. CAGR % | 14.17 | 11.66 | 9.66 | 0.82 | -2.74 | |||||
Cash From Operations, 5 Yr. CAGR % | 31.21 | 1.62 | -28.45 | -23.44 | 35.24 | |||||
Capital Expenditures, 5 Yr. CAGR % | 44.33 | 50.07 | 4.56 | -33.02 | -24 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 48.38 | 9.16 | 158.26 | 9.54 | 22.58 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 47.5 | 8.99 | 144.72 | 10.4 | 22.42 |
Select your edition
All financial news and data tailored to specific country editions
















